Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Heparin Anticoagulation to Improve Outcomes in Septic Shock: The HALO Pilot

NCT01648036 is registered in ClinicalTrials.gov with University of Manitoba as lead sponsor.

NCT NCT01648036
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01648036 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Heparin Anticoagulation to Improve Outcomes in Septic Shock: The HALO Pilot
Lead sponsor
University of Manitoba
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2012
Completion date
February 28, 2014
Enrollment
76 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

septic shock